XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 69 filers reported holding XERIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $26,672,000 | -9.8% | 6,553,398 | 0.0% | 0.47% | -23.7% |
| Q1 2021 | $29,556,000 | +249.6% | 6,553,398 | +106.2% | 0.62% | +152.4% |
| Q2 2020 | $8,455,000 | +26.3% | 3,178,551 | -7.4% | 0.25% | +16.0% |
| Q1 2020 | $6,695,000 | -63.2% | 3,433,291 | +32.9% | 0.21% | -63.5% |
| Q4 2019 | $18,212,000 | -19.7% | 2,583,291 | +11.9% | 0.58% | -37.2% |
| Q3 2019 | $22,694,000 | -16.6% | 2,308,666 | -3.0% | 0.92% | -5.4% |
| Q2 2019 | $27,226,000 | +15.1% | 2,379,901 | +1.1% | 0.98% | +7.8% |
| Q1 2019 | $23,646,000 | -44.3% | 2,355,136 | -5.7% | 0.91% | -46.6% |
| Q4 2018 | $42,477,000 | -3.3% | 2,498,666 | 0.0% | 1.70% | +8.0% |
| Q3 2018 | $43,927,000 | -7.4% | 2,498,666 | 0.0% | 1.57% | -5.5% |
| Q2 2018 | $47,425,000 | – | 2,498,666 | – | 1.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,000,641 | $29,496,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,308,666 | $22,694,000 | 0.92% |
| ArrowMark Colorado Holdings LLC | 1,656,422 | $16,283,000 | 0.16% |
| IHT Wealth Management, LLC | 57,028 | $561,000 | 0.08% |
| MOORE CAPITAL MANAGEMENT, LP | 50,000 | $492,000 | 0.02% |
| Engineers Gate Manager LP | 20,264 | $199,000 | 0.01% |
| FEDERATED HERMES, INC. | 300,000 | $2,949,000 | 0.01% |
| FMR LLC | 4,048,102 | $39,793,000 | 0.01% |
| Invesco Ltd. | 1,000,000 | $9,830,000 | 0.00% |
| MetLife Investment Management, LLC | 14,041 | $138,023 | 0.00% |